Mergers & Acquisitions (M&A) in Israel

Israel is one of the most active M&A markets in the Middle East and globally, driven by a dense concentration of technology companies, life sciences firms and defence-adjacent businesses. International acquirers face a legal environment that combines familiar common-law principles with distinct Israeli statutory requirements, mandatory regulatory approvals and a sophisticated antitrust regime. Getting the structure wrong - or underestimating the pre-closing compliance burden - can delay a deal by months or expose the buyer to material post-closing liability. This article covers deal structures available under Israeli law, the due diligence process, regulatory and antitrust clearances, key contractual protections, and the most frequent mistakes made by foreign buyers in Israeli M&A transactions.

Israeli corporate law offers three primary transaction structures: a share deal, an asset deal and a statutory merger. Each carries a different risk profile, tax treatment and procedural burden.

A share deal is the most common structure for acquiring an Israeli private company. The buyer acquires the target's shares directly from existing shareholders, stepping into the company's legal shoes with all its assets, contracts and liabilities. Under the Companies Law, 5759-1999 (the principal statute governing Israeli corporations), the transfer of shares in a private company requires compliance with any transfer restrictions in the articles of association and, where applicable, a shareholders' agreement. A common mistake among foreign buyers is to assume that a clean cap table eliminates hidden liabilities - Israeli courts have consistently held that undisclosed tax exposures and employment claims survive a share transfer.

An asset deal allows the buyer to cherry-pick specific assets and liabilities, leaving unwanted obligations with the seller. This structure is more complex operationally: each asset class - intellectual property, real estate, contracts, licences - requires a separate transfer mechanism. Under the Contract Law (General Part), 5733-1973, assignment of contracts requires counterparty consent unless the contract expressly permits assignment. In practice, obtaining consent from dozens of counterparties adds weeks to the timeline and creates negotiating leverage for third parties.

A statutory merger under the Companies Law (Sections 314-327) is a court-supervised process that results in one entity absorbing another by operation of law. All assets and liabilities transfer automatically without individual assignment. The procedural burden is significant: the merger requires board and shareholder approval at both companies, a court application to the District Court, creditor notification and a minimum waiting period of approximately 70 days from the date of the court order. Statutory mergers are therefore most practical for larger, strategically important transactions where the automatic transfer of regulated licences or complex contracts justifies the delay.

A joint venture in Israel is typically structured either as a contractual arrangement or through a newly incorporated Israeli company. The Companies Law imposes mandatory fiduciary duties on directors and controlling shareholders, which means joint venture governance documents must be drafted carefully to avoid conflicts between the statutory framework and the commercial deal. Many international investors underappreciate that Israeli law does not permit unlimited exclusion of these duties by contract.

Due diligence in an Israeli M&A transaction covers legal, financial, tax and technical dimensions, but several areas require particular attention given local legal specificities.

Corporate and ownership diligence begins with the Companies Registrar (Registrar of Companies), which maintains publicly accessible records of incorporation, share capital, charges and officer appointments. A non-obvious risk is that the Registrar's records may lag behind actual ownership changes by several weeks, making direct confirmation from the target's corporate secretary essential. Charges over assets are registered separately with the Pledges Registrar, and a search of both registries is mandatory before signing.

Employment diligence is disproportionately important in Israeli transactions. Israeli labour law - primarily the Employment (Equal Opportunities) Law, 5748-1988, the Annual Leave Law, 5711-1951 and the Severance Pay Law, 5723-1963 - creates significant mandatory entitlements that cannot be waived by contract. Accrued severance obligations, unused vacation liabilities and pension fund contributions must be quantified precisely. A common mistake is to treat Israeli employment liabilities as equivalent to those in continental European jurisdictions: the mandatory severance regime under Section 1 of the Severance Pay Law applies broadly and can represent a material balance-sheet exposure in labour-intensive businesses.

Intellectual property diligence is critical for technology targets. Israel's Patent Law, 5727-1967 and the Copyright Law, 5768-2007 govern registration and ownership of core IP. A recurring issue is the 'employee invention' problem: under the Patent Law, inventions created by employees in the course of their employment belong to the employer, but this presumption can be rebutted where the invention was developed outside working hours or without company resources. Buyers should verify that all key developers have signed comprehensive IP assignment agreements and that no invention ownership disputes are pending or threatened.

Tax diligence must address Israeli capital gains tax exposure at the shareholder level and any outstanding assessments from the Israel Tax Authority (ITA). Under the Income Tax Ordinance (New Version), 5721-1961, capital gains on the sale of shares in an Israeli company are generally taxable in Israel for both residents and non-residents, subject to applicable tax treaties. The ITA has broad powers to recharacterise transactions, and buyers should obtain tax opinions or advance rulings where the structure involves complex inter-company arrangements.

Real estate diligence in Israel is governed by the Land Law, 5729-1969. Israel operates a Torrens-style land registration system through the Land Registry (Tabu). Unregistered interests and long-term lease arrangements (particularly on Israel Lands Authority land, which constitutes the majority of land in Israel) require careful review, as they may not appear on the face of the title register.

To receive a checklist for conducting M&A due diligence in Israel, send a request to info@vlo.com.

Israeli M&A transactions are subject to a layered approval regime that can significantly affect deal timing and certainty.

Antitrust clearance is administered by the Israel Competition Authority (ICA), operating under the Economic Competition Law, 5748-1988. A merger must be notified to the ICA where the combined annual turnover of the parties in Israel exceeds the statutory threshold (currently set by regulation and subject to periodic revision) or where the transaction results in a market share above a defined level. The ICA has the power to approve, conditionally approve or block a transaction. Review periods vary: a standard review takes up to 30 days from a complete filing, but the ICA may extend this period for complex transactions. Failure to notify a notifiable transaction exposes the parties to administrative fines and potential transaction unwinding.

Sector-specific approvals apply in regulated industries. In telecommunications, the Ministry of Communications must approve changes of control under the Communications Law (Bezeq and Broadcasts), 5742-1982. In banking and financial services, the Bank of Israel and the Capital Market, Insurance and Savings Authority exercise control over ownership changes. In defence and dual-use technology, the Ministry of Defence's Directorate of Defence Research and Development (DDR&D) and the export control regime under the Control of Exports Law, 5766-2006 may require approval or impose post-closing restrictions on technology transfer.

Foreign investment screening has become increasingly relevant. Israel does not yet operate a comprehensive foreign direct investment (FDI) screening regime equivalent to CFIUS in the United States or the EU's FDI Regulation framework, but sector-specific controls effectively perform a similar function in sensitive industries. International buyers in technology, cybersecurity and defence-adjacent sectors should conduct a thorough regulatory mapping exercise before signing.

A practical scenario: a US strategic buyer acquiring a mid-sized Israeli cybersecurity company will typically face ICA notification (if turnover thresholds are met), DDR&D review of any dual-use technology, and ITA engagement on the tax structure. Managing these parallel tracks requires a coordinated timeline built into the transaction documents, with appropriate conditions precedent and long-stop dates.

Israeli M&A contracts are typically governed by Israeli law and follow a structure broadly familiar to practitioners from common-law jurisdictions, but with important local variations.

The share purchase agreement (SPA) in an Israeli transaction will include representations and warranties, indemnities, conditions precedent, closing mechanics and post-closing adjustments. Under Israeli contract law - primarily the Contract Law (Remedies for Breach of Contract), 5731-1970 - a buyer who discovers a misrepresentation has the right to rescind the contract or claim damages, but the interaction between contractual indemnities and statutory remedies requires careful drafting to avoid unintended outcomes.

Representations and warranties insurance (RWI) is increasingly used in Israeli M&A, particularly in private equity transactions and cross-border deals. The Israeli insurance market for RWI has developed significantly, and international insurers are active. RWI shifts the risk of warranty breach from the seller to an insurer, facilitating cleaner exits for sellers and providing buyers with a creditworthy counterparty for claims. A non-obvious risk is that Israeli law imposes a duty of disclosure on the insured, and failure to disclose material facts known at the time of policy inception can void coverage.

Escrow arrangements are standard in Israeli transactions where the seller is a natural person or a holding entity that will be wound up post-closing. Escrow funds are typically held by an Israeli bank or a licensed escrow agent for 12-24 months, covering the indemnity period for general representations. Tax representations typically survive for the applicable statute of limitations under the Income Tax Ordinance, which is generally six years from the end of the tax year in which the return was filed.

Earn-out provisions are common in technology and life sciences transactions where the parties disagree on valuation. Israeli courts have interpreted earn-out provisions strictly, applying the general principle under the Contract Law (General Part) that contracts must be performed in good faith. Buyers who take post-closing actions that reduce earn-out payments without legitimate business justification face litigation risk under this good-faith obligation.

A second practical scenario: a European private equity fund acquiring a controlling stake in an Israeli SaaS company structures the deal with a 15% escrow held for 18 months, RWI covering general representations, and a two-year earn-out tied to ARR growth. The earn-out mechanism must be drafted to define clearly what actions the buyer may or may not take in managing the business during the earn-out period - ambiguity here is a frequent source of post-closing disputes.

To receive a checklist for structuring M&A transaction documents under Israeli law, send a request to info@vlo.com.

Post-closing integration in Israel regularly surfaces three categories of risk that were underweighted during due diligence: employment liabilities, IP ownership gaps and tax reassessments.

Employment liabilities crystallise most acutely in asset deals and restructurings. Under the Severance Pay Law, an employee dismissed without cause is entitled to one month's severance for each year of service. Where the transaction involves a transfer of business, Israeli courts have developed a doctrine analogous to TUPE in English law: employees may be entitled to treat the transfer as a constructive dismissal triggering severance if their terms are materially worsened. Buyers who restructure the workforce immediately after closing without proper legal preparation regularly face class-action claims before the National Labour Court.

IP ownership gaps are particularly prevalent in early-stage technology companies where founders and early developers were not subject to comprehensive IP assignment agreements. Under the Copyright Law, moral rights in software cannot be assigned - only waived - and the waiver must be express. A buyer who discovers post-closing that key software modules were developed by contractors who retained copyright has limited remedies other than negotiating a licence or rewriting the code.

Tax reassessments by the ITA can arise years after closing. The ITA has the power to reassess a company's tax returns for up to six years (and longer in cases of fraud or material omission). Transfer pricing adjustments are a common trigger, particularly where the target had inter-company arrangements with related parties. Buyers should negotiate specific tax indemnities covering pre-closing periods and consider requesting an advance tax ruling from the ITA on the transaction structure before closing.

A third practical scenario: a Japanese strategic acquirer of an Israeli medical device company discovers 18 months post-closing that the target's R&D subsidiary had not properly documented its transfer pricing arrangements with the parent. The ITA issues a reassessment covering multiple prior years, resulting in a tax liability that significantly exceeds the escrow balance. The buyer's recourse is limited to pursuing the sellers directly under the tax indemnity - a process that may involve litigation in Israeli courts.

The risk of inaction is concrete: buyers who delay engaging Israeli tax counsel until after signing regularly find that the deal structure cannot be unwound without triggering additional tax costs, and that the window for obtaining an advance ruling has closed.

International buyers entering the Israeli M&A market face a combination of legal, cultural and operational factors that distinguish Israeli transactions from deals in other jurisdictions.

Negotiation culture in Israel is direct and fast-paced. Sellers - particularly founders of technology companies - expect counterparties to engage substantively on deal terms quickly. Prolonged due diligence processes or slow responses to term sheets can signal lack of commitment and cause sellers to engage with competing bidders. In practice, it is important to consider that Israeli founders often have multiple acquisition approaches simultaneously and will not hold exclusivity indefinitely without meaningful progress.

Language and documentation: transaction documents in Israeli M&A are typically drafted in English, even where both parties are Israeli. This reflects the international orientation of the Israeli technology sector and the prevalence of US-trained lawyers. However, regulatory filings with the ICA, the Companies Registrar and sector regulators are submitted in Hebrew, and official corporate documents (articles of association, board resolutions) are often in Hebrew. Buyers should ensure their legal team includes Hebrew-language capability.

Governing law and dispute resolution: most Israeli M&A contracts are governed by Israeli law. Dispute resolution clauses vary - some transactions specify Israeli court jurisdiction (typically the Tel Aviv District Court for commercial matters), while others provide for international arbitration under ICC or LCIA rules. The Tel Aviv District Court has a dedicated Economic Division with experienced commercial judges, and Israeli court proceedings are generally efficient by regional standards. Arbitration is preferred where confidentiality is important or where the counterparty is a foreign entity that may resist enforcement of Israeli judgments.

Costs and timeline: legal fees for a mid-market Israeli M&A transaction (deal value in the range of tens of millions of USD) typically start from the low tens of thousands of USD for each side, scaling with complexity. Regulatory filing fees are modest. The overall timeline from signing of a term sheet to closing typically ranges from 60 to 120 days for a straightforward private company acquisition, extending to six months or more where ICA review, sector-specific approvals or complex tax structuring is required.

A common mistake among international buyers is to underestimate the time required for ICA review and to build insufficient buffer into the long-stop date. A transaction that expires before regulatory clearance is obtained creates significant legal and commercial complications, including potential liability for break fees.

Loss caused by incorrect strategy is not hypothetical: buyers who structure Israeli acquisitions without local legal advice regularly encounter post-closing claims that could have been addressed through proper due diligence and contractual protections. The cost of non-specialist mistakes - in terms of unindemnified liabilities, failed regulatory clearances and post-closing disputes - routinely exceeds the cost of comprehensive legal support.

We can help build a strategy for your Israeli M&A transaction, including deal structuring, due diligence coordination and regulatory engagement. Contact info@vlo.com.

What are the main risks of acquiring an Israeli technology company without specialist legal advice?

The principal risks fall into three categories: undisclosed employment liabilities (particularly accrued severance and pension obligations), IP ownership gaps arising from inadequate assignment agreements with founders and contractors, and tax exposures from ITA reassessments of pre-closing periods. Israeli labour law creates mandatory entitlements that cannot be contractually excluded, and the ITA has broad powers to recharacterise transactions and adjust transfer pricing. Without specialist advice, buyers frequently discover these issues only after closing, when remedies are limited to pursuing sellers under contractual indemnities - a process that may involve protracted litigation.

How long does an Israeli M&A transaction typically take, and what drives delays?

A straightforward acquisition of a private Israeli company with no regulatory issues typically closes within 60 to 90 days of signing. The main drivers of delay are ICA antitrust review (which can extend to 30 days or more from a complete filing, with the possibility of further extension in complex cases), sector-specific regulatory approvals (which have their own timelines and are not always predictable), and tax structuring issues requiring advance rulings from the ITA. Complex transactions involving multiple regulatory tracks regularly take five to six months from signing to closing. Buyers should build realistic long-stop dates into their SPAs and include appropriate conditions precedent for each required approval.

When is a statutory merger preferable to a share deal in Israel?

A statutory merger under the Companies Law is preferable where the automatic transfer of assets and liabilities by operation of law provides a material advantage - for example, where the target holds regulated licences that cannot be individually assigned, or where the target has a large number of contracts that would require individual counterparty consent in an asset deal. The trade-off is procedural: a statutory merger requires court approval, creditor notification and a minimum waiting period of approximately 70 days, making it significantly slower than a share deal. For most private company acquisitions, a share deal is more efficient. The statutory merger structure is most commonly used in public company transactions and intra-group reorganisations where the automatic transfer mechanism justifies the additional procedural burden.

Israeli M&A offers genuine opportunities for international buyers, but the legal environment rewards preparation and penalises shortcuts. The combination of a sophisticated antitrust regime, mandatory employment protections, complex IP ownership rules and an active tax authority means that deal success depends heavily on the quality of due diligence, the robustness of contractual protections and the accuracy of regulatory mapping. Buyers who invest in proper legal structuring before signing consistently achieve better outcomes than those who treat Israeli transactions as equivalent to deals in more familiar jurisdictions.

To receive a checklist for managing the full M&A process in Israel - from term sheet to post-closing integration - send a request to info@vlo.com.

Our law firm Vetrov & Partners has experience supporting clients in Israel on mergers and acquisitions matters. We can assist with deal structuring, due diligence coordination, regulatory filings, SPA negotiation and post-closing dispute resolution. To receive a consultation, contact: info@vlo.com.